Drugs / BioDRestore Elemental Tissue Matrix
BioDRestore Elemental Tissue Matrix
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03770546 | Oct 2021 → Dec 2022 | frozen shoulder, osteoarthritis | University of Alabama at Birmingham | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BioDRestore Elemental Tissue Matrix | “BioDRestore Elemental Tissue Matrix is a morselized, flowable tissue allograft derived from human amniotic tissues.” NCT03770546 ↗ |
| Modality | Other / unclassified | “BioDRestore Elemental Tissue Matrix is a morselized, flowable tissue allograft derived from human amniotic tissues.” NCT03770546 ↗ |